BRIEF-Cardiome Pharma says announces XYDALBA single dose infusion approval by european medicines agency

Tue Aug 9, 2016 4:32pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 9 (Reuters) - Cardiome Pharma Corp

* Cardiome announces XYDALBA single dose infusion approval by european medicines agency

* Anticipate XYDALB will be available to physicians within some of major territories under license by cardiome during q4 of 2016 Source text for Eikon: Further company coverage: